Development of stem cell-based therapy for Parkinson's disease

Translational Neurodegeneration
Fabin HanQingfa Chen

Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative disorders of aging, characterized by the degeneration of dopamine neurons (DA neurons) in the substantial nigra, leading to the advent of both motor symptoms and non-motor symptoms. Current treatments include electrical stimulation of the affected brain areas and dopamine replacement therapy. Even though both categories are effective in treating PD patients, the disease progression cannot be stopped. The research advance into cell therapies provides exciting potential for the treatment of PD. Current cell sources include neural stem cells (NSCs) from fetal brain tissues, human embryonic stem cells (hESCs), induced pluripotent stem cells (iPSCs) and directly induced dopamine neurons (iDA neurons). Here, we evaluate the research progress in different cell sources with a focus on using iPSCs as a valuable source and propose key challenges for developing cells suitable for large-scale clinical applications in the treatment of PD.

References

Jun 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·W R Gibb, A J Lees
Aug 28, 1965·Nature·J Altman, G D Das
Feb 27, 1997·Nature·I WilmutK H Campbell
Nov 6, 1998·Science·J A ThomsonJ M Jones
Feb 3, 1999·JAMA : the Journal of the American Medical Association·C M TannerJ W Langston
Jul 23, 1999·Brain Pathology·C N SvendsenT Ostenfeld
Mar 10, 2001·The New England Journal of Medicine·C R FreedS Fahn
Mar 29, 2001·Neurology·D AarslandP Kragh-Sørensen
Aug 7, 2001·Journal of Neuropathology and Experimental Neurology·P Hagell, P Brundin
Sep 3, 2002·Journal of Neuroscience Research·Philippe Taupin, Fred H Gage
Sep 4, 2003·Annals of Neurology·C Warren OlanowThomas B Freeman
Aug 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Anselme L PerrierLorenz Studer
Nov 13, 2004·Stem Cells·Xianmin ZengWilliam J Freed
Dec 14, 2004·The New England Journal of Medicine·Stanley FahnUNKNOWN Parkinson Study Group
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Olle Lindvall, Anders Björklund
Sep 13, 2005·Cell·Laurie A BoyerRichard A Young
Feb 21, 2006·Lancet Neurology·K Ray ChaudhuriUNKNOWN National Institute for Clinical Excellence
Mar 15, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·David A GrimesDennis E Bulman
Jul 11, 2006·The Journal of Clinical Investigation·Joseph M SavittTed M Dawson
Jul 27, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Thomas CarlssonDeniz Kirik
Nov 22, 2007·Science·Junying YuJames A Thomson
Dec 7, 2007·Nature Biotechnology·Masato NakagawaShinya Yamanaka
Apr 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Marius WernigRudolf Jaenisch
Apr 9, 2008·Nature Medicine·Jeffrey H KordowerC Warren Olanow

❮ Previous
Next ❯

Citations

Jun 24, 2016·Neural Regeneration Research·Mária CsöbönyeiováŠtefan Polák
Jan 25, 2017·International Journal of Molecular Sciences·Dong-Hee ChoiJongmin Lee
May 10, 2017·Materials Science & Engineering. C, Materials for Biological Applications·Hanieh MoradianShahab Faghihi
Nov 24, 2016·Ageing Research Reviews·Yuan WangGuodong Cao
Jun 9, 2018·Stem Cells and Development·Ibon GaritaonandiaRussell Kern
Sep 22, 2018·Stem Cells Translational Medicine·Bárbara Mendes-PinheiroAntónio J Salgado
Apr 2, 2019·Critical Reviews in Clinical Laboratory Sciences·Aroa Relaño-GinésChristophe Hirtz
Oct 24, 2019·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Vahid EbrahimiYousef Sadeghi
Apr 29, 2020·Biotechnology Letters·Hamid Ahmadian-MoghadamMohammad-Reza Zarrindast
Nov 24, 2016·Frontiers in Molecular Biosciences·Shripriya SinghChetan S Rajpurohit
Nov 2, 2017·Translational Neurodegeneration·Panchanan MaitiGary L Dunbar
Jun 12, 2018·Journal of Parkinson's Disease·Stephen PolgarMonica Busse
Dec 16, 2020·Neural Regeneration Research·Zhong-Yue LvJing Liu
Nov 4, 2020·International Journal of Molecular Sciences·Zhaohui Liu, Hoi-Hung Cheung
Jan 31, 2020·Journal of Chemical Neuroanatomy·Sachchida Nand Rai, Payal Singh
Mar 7, 2021·International Journal of Molecular Sciences·Farzane Sivandzade, Luca Cucullo

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
genotyping
FACS

Related Concepts

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Genetics & Epigenetics of Aging

Dozens of genes are implicated in lifespan, and epigenetic changes during aging affect cell function. This feed focuses on the genetics and epigenetics of aging.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Related Papers

Expert Review of Neurotherapeutics
Sean C Dyson, Roger A Barker
Rinshō shinkeigaku = Clinical neurology
Tetsuro Shingo
Journal of Neural Transmission. Supplementum
K-C SonntagR Sanchez-Pernaute
© 2021 Meta ULC. All rights reserved